CSF YKL-40 was significantly elevated in AD, MCI, MCI-AD, and stable MCI compared to the controls, and it was higher in MCI-AD than in the stable MCI (Mavroudis I. et al., 2021). This evidence concerns the gene CHI3L1 and Alzheimer disease.